Effect of spironolactone on cardiacsympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy

This publication has 31 references indexed in Scilit:

• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients.
  Published by Oxford University Press (OUP) ,1998
• Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive Rats
  Hypertension, 1998
• Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients
  Cardiovascular Research, 1997
• Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease
  The American Journal of Cardiology, 1995
• Chronic administration of aldosterone depresses baroreceptor reflex function in the dog.
  Hypertension, 1994
• Aldosterone and antialdosterone therapy in congestive heart failure
  The American Journal of Cardiology, 1993
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.
  Circulation, 1990
• Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.
  Circulation, 1988
• Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.
  Circulation, 1981